Holen Sie sich die Stockscreener-App
0.8499
4.58%
0.0372
Schlusskurs vom Vortag:
$0.8127
Offen:
$0.849
24-Stunden-Volumen:
29,088
Relative Volume:
0.09
Marktkapitalisierung:
$12.69M
Einnahmen:
Nettoeinkommen (Verlust:
$-15.91M
KGV:
-0.5882
EPS:
-1.445
Netto-Cashflow:
$-15.07M
1W Leistung:
-9.59%
1M Leistung:
-50.30%
6M Leistung:
-56.86%
1J Leistung:
-80.42%
1-Tages-Spanne:
$0.7772
$0.85
1-Wochen-Bereich:
$0.7603
$1.07
52-Wochen-Spanne:
$0.7603
$4.6891
Lantern Pharma Inc Stock (LTRN) Company Profile
Firmenname
Lantern Pharma Inc
Sektor
Branche
Telefon
972-277-1136
Adresse
1920 MCKINNEY AVENUE, DALLAS, TX
Compare LTRN vs VRTX, MRNA, REGN, ARGX, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LTRN
Lantern Pharma Inc
|
0.8499 | 12.69M | 0 | -15.91M | -15.07M | -1.445 |
VRTX
Vertex Pharmaceuticals Inc
|
511.27 | 129.59B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
223.12 | 89.08B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
758.41 | 78.08B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
827.96 | 52.07B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
189.91 | 40.70B | 742.00K | -1.37B | -1.07B | -7.0731 |
Lantern Pharma Inc Stock (LTRN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-10-07 | Eingeleitet | H.C. Wainwright | Buy |
Lantern Pharma Inc Aktie (LTRN) Neueste Nachrichten
Lantern Pharma Schedules Virtual 2026 Annual Meeting with Seven Key Proposals on December 1 - Kalkine Media
With 281,597 shares unissued and unreserved, Lantern Pharma (LTRN) proposes a higher share limit. - Stock Titan
More than half of Taiwan’s lung cancer patients never smoked. A trial site there is screening patients. - Stock Titan
Lantern Pharma Inc. (LTRN) stock price, news, quote and history - Yahoo Finance Australia
Lantern Pharma Inc. (LTRN) stock price, news, quote and history - Yahoo Finance UK
Lantern Pharma Inc. Announces Closing of up to $8 Million Registered Direct Offering - BioSpace
Lantern Pharma closes $4 million stock offering By Investing.com - Investing.com South Africa
Lantern Pharma closes $4 million stock offering By Investing.com - Investing.com Canada
Lantern Pharma closes $4 million stock offering By Investing.com - Investing.com Nigeria
Lantern Pharma closes $4 million stock offering By Investing.com - Investing.com India
Lantern Pharma Raises $4.0 Million in Registered Direct; Issues Warrants, Engages Rodman & Renshaw - TradingView
Lantern Pharma closes $4 million stock offering By Investing.com - Investing.com UK
Lantern Pharma Inc. Announces Closing of up to $8 Million Registered Direct Offering - Business Wire
Form 424B5 Lantern Pharma Inc For: 30 September By Investing.com - Investing.com South Africa
Form 424B5 Lantern Pharma Inc For: 30 September By Investing.com - Investing.com Nigeria
Form 424B5 Lantern Pharma Inc For: 30 September By Investing.com - Investing.com Canada
Lantern Pharma raises $4M in registered direct offering - Investing.com
Lantern Pharma announces up to $8M registered direct offering - TradingView
Lantern Pharma Inc. Announces up to $8 Million Registered Direct Offering - Business Wire
Lantern Pharma Inc. (LTRN) Stock Price, News, Quote & History - Yahoo! Finance Canada
Form 8K Lantern Pharma Inc For: 24 September By Investing.com - Investing.com Nigeria
Form 8K Lantern Pharma Inc For: 24 September By Investing.com - Investing.com India
Form 8K Lantern Pharma Inc For: 24 September By Investing.com - Investing.com UK
Form 8K Lantern Pharma Inc For: 23 September By Investing.com - Investing.com Nigeria
Form 8K Lantern Pharma Inc For: 23 September By Investing.com - Investing.com UK
A cancer drug could gain patent protection through 2042. Lantern Pharma’s LP-284 targets two blood cancers. - Stock Titan
Lantern Pharma Inc (NASDAQ: LTRN) Share Price, LTRN Stock News, LTRN Share Price & Updates - kalkine.ca
Lantern Pharma Q2 2026 Earnings Call: Complete Transcript - benzinga.com
Lantern Pharma Share PriceLTRN, RNS News, Articles, Quotes, & Charts (NASDAQ:LTRN) - Proactive financial news
New to The Street Broadcasts at 6:30 PM ET Across Bloomberg U.S., Latin America and MENA, Featuring Lantern Pharma (NASDAQ:LTRN), SafeSpace Global (OTCID:SSGC) and FreeCast (NASDAQ:CAST) - guardonline.com
New to The Street Broadcasts at 6:30 PM ET Across Bloomberg U.S., Latin America and MENA, Featuring Lantern Pharma (NASDAQ:LTRN), SafeSpace Global (OTCID:SSGC) and FreeCast (NASDAQ:CAST) - 富途牛牛
New to The Street Broadcasts at 6:30 PM ET Across Bloomberg U.S., Latin America and MENA, Featuring Lantern Pharma (NASDAQ:LTRN), SafeSpace Global (OTCID:SSGC) and FreeCast (NASDAQ:CAST) - Yahoo Finance
Lantern Pharma Inc. (LTRN) Stock Price & News - Syfe
Lantern Pharma Earnings Call: AI Spinout, Trial Momentum - TipRanks
Lantern Pharma (LTRN) Q2 2026 Earnings Call Transcript - AOL.com
Lantern Pharma (LTRN) Q2 2026 Earnings Call Transcript - The Globe and Mail
Here's Why We're A Bit Worried About Lantern Pharma's (NASDAQ:LTRN) Cash Burn Situation - Sahm
Lantern Pharma Inc (LTRN) (Q2 2026) Earnings Call Highlights: AI - GuruFocus
Lantern Pharma Inc (LTRN) (Q2 2026) Earnings Call Highlights: AI-Driven Pipeline Advances Amid ... - Yahoo Finance
Lantern Pharma Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Lantern Pharma Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:LTRN) 2026-08-17 - Seeking Alpha
Lantern Pharma (LTRN) Slides 2.26% as Biotech Stock Approaches Critical $2.46 SupportKey Reversal Day - vinanet.vn
Lantern Pharma (LTRN) Updates Trial Design Amid Cash Raise; Mark - GuruFocus
Lantern Pharma (LTRN) Edges Up 0.76% to $2.65: Rangebound Trading Between Support and ResistanceBull Pennant - vinanet.vn
Lantern Pharma (LTRN) Edges Up 0.76% to $2.65: Rangebound Trading Between Support and ResistanceFRAMA Signal - dars.gov.et
Lantern Pharma (LTRN) Edges Up 0.76% to $2.65: Rangebound Trading Between Support and ResistanceVolume Profile - careplusvn.com
Lantern Pharma (LTRN) Edges Up 0.76% to $2.65: Rangebound Trading Between Support and ResistanceCall Flow Alert - dars.gov.et
Form 8K Lantern Pharma Inc For: 14 August By Investing.com - Investing.com Nigeria
LTRN: Static price chart | Lantern Pharma Inc. | US51654W1018 - marketscreener.com
Lantern Pharma Releases Q2 2026 Financial Results - AlphaStreet
Finanzdaten der Lantern Pharma Inc-Aktie (LTRN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Lantern Pharma Inc-Aktie (LTRN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| KEYSER D JEFFREY | Director |
May 12 '26 |
Buy |
2.06 |
48,544 |
100,001 |
94,303 |
2.54%
0.54%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):